T. Rowe Price Associates’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$410K Buy
91,050
+16,508
+22% +$86K ﹤0.01% 2535
2025
Q4
$459K Buy
74,542
+14,268
+24% +$103K ﹤0.01% 2436
2025
Q3
$436K Buy
60,274
+5,098
+9% +$30.3K ﹤0.01% 2423
2025
Q2
$293K Buy
55,176
+7,029
+15% +$41.5K ﹤0.01% 2543
2025
Q1
$428K Buy
48,147
+4,058
+9% +$48.7K ﹤0.01% 2315
2024
Q4
$605K Sell
44,089
-10,253
-19% -$189K ﹤0.01% 2204
2024
Q3
$1.49M Sell
54,342
-2,674
-5% -$72.4K ﹤0.01% 1778
2024
Q2
$1.4M Buy
57,016
+3,448
+6% +$75.7K ﹤0.01% 1739
2024
Q1
$1.14M Buy
53,568
+6,337
+13% +$136K ﹤0.01% 1854
2023
Q4
$905K Buy
47,231
+440
+0.9% +$7.61K ﹤0.01% 1911
2023
Q3
$751K Buy
46,791
+3,652
+8% +$69.5K ﹤0.01% 1927
2023
Q2
$1M Buy
43,139
+2,405
+6% +$52.5K ﹤0.01% 1812
2023
Q1
$947K Buy
40,734
+1,163
+3% +$23.6K ﹤0.01% 1815
2022
Q4
$574K Buy
39,571
+1,077
+3% +$20.1K ﹤0.01% 2075
2022
Q3
$735K Buy
38,494
+5,160
+15% +$118K ﹤0.01% 1927
2022
Q2
$606K Buy
33,334
+509
+2% +$10.6K ﹤0.01% 2142
2022
Q1
$827K Buy
32,825
+923
+3% +$23.6K ﹤0.01% 2094
2021
Q4
$880K Sell
31,902
-2,919
-8% -$84.6K ﹤0.01% 2094
2021
Q3
$1.12M Buy
34,821
+100
+0.3% +$3.32K ﹤0.01% 2007
2021
Q2
$1.06M Buy
34,721
+4,964
+17% +$143K ﹤0.01% 2058
2021
Q1
$906K Sell
29,757
-11,221
-27% -$318K ﹤0.01% 2103
2020
Q4
$810K Sell
40,978
-15,205
-27% -$246K ﹤0.01% 2036
2020
Q3
$733K Hold
56,183
﹤0.01% 1945
2020
Q2
$637K Buy
56,183
+641
+1% +$9.1K ﹤0.01% 1967
2020
Q1
$795K Buy
55,542
+410
+0.7% +$8.66K ﹤0.01% 1794
2019
Q4
$1.5M Buy
55,132
+22,942
+71% +$631K ﹤0.01% 1708
2019
Q3
$922K Buy
32,190
+348
+1% +$10.1K ﹤0.01% 1859
2019
Q2
$885K Buy
31,842
+173
+0.5% +$4.89K ﹤0.01% 1890
2019
Q1
$1.05M Buy
31,669
+670
+2% +$20.4K ﹤0.01% 1825
2018
Q4
$901K Buy
30,999
+6,746
+28% +$243K ﹤0.01% 1838
2018
Q3
$1.12M Sell
24,253
-18
-0.1% -$800 ﹤0.01% 1843
2018
Q2
$907K Buy
24,271
+76
+0.3% +$2.57K ﹤0.01% 1885
2018
Q1
$715K Buy
24,195
+127
+0.5% +$4.3K ﹤0.01% 1938
2017
Q4
$827K Sell
24,068
-5,820
-19% -$196K ﹤0.01% 1876
2017
Q3
$1.08M Hold
29,888
﹤0.01% 1783
2017
Q2
$772K Hold
29,888
﹤0.01% 1884
2017
Q1
$574K Buy
29,888
+8
+0% +$142 ﹤0.01% 2012
2016
Q4
$498K Hold
29,880
﹤0.01% 2038
2016
Q3
$615K Buy
29,880
+11,500
+63% +$292K ﹤0.01% 1929
2016
Q2
$562K Sell
18,380
-3,200
-15% -$111K ﹤0.01% 1919
2016
Q1
$808K Buy
21,580
+4,900
+29% +$185K ﹤0.01% 1781
2015
Q4
$720K Buy
16,680
+2,480
+17% +$105K ﹤0.01% 1805
2015
Q3
$532K Sell
14,200
-10,390
-42% -$369K ﹤0.01% 1921
2015
Q2
$836K Sell
24,590
-103,010
-81% -$3.5M ﹤0.01% 1811
2015
Q1
$4.52M Hold
127,600
﹤0.01% 1485
2014
Q4
$4.35M Hold
127,600
﹤0.01% 1481
2014
Q3
$4.92M Hold
127,600
﹤0.01% 1457
2014
Q2
$4.97M Buy
127,600
+2,000
+2% +$74.4K ﹤0.01% 1457
2014
Q1
$4.29M Sell
125,600
-800
-0.6% -$24.8K ﹤0.01% 1450
2013
Q4
$2.65M Sell
126,400
-2,800
-2% -$70.8K ﹤0.01% 1498
2013
Q3
$3.04M Buy
129,200
+1,000
+0.8% +$28.4K ﹤0.01% 1482
2013
Q2
$3.44M Buy
+128,200
New +$3.72M ﹤0.01% 1461

Other funds holding MYGN